Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Abukhattab, S.; Hosch, S.; Abu-Rmeileh, N. M. E.; Hasan, S.; Vonaesch, P.; Crump, L.; Hattendorf, J.; Daubenberger, C.; Zinsstag, J.; Schindler, T.
2023
Whole-genome sequencing for One Health surveillance of antimicrobial resistance in conflict zones: a case study of Salmonella spp. and Campylobacter spp. in the West Bank, Palestine
Abukhattab, S.; Taweel, H.; Awad, A.; Crump, L.; Vonaesch, P.; Zinsstag, J.; Hattendof, J.; Abu-Rmeileh, N. M. E.
2022
Systematic review and meta-analysis of integrated studies on salmonella and campylobacter prevalence, serovar, and phenotyping and genetic of antimicrobial resistance in the middle east-a One Health perspective
Three-year rates of reoperation and revision following mobile versus fixed-bearing total ankle arthroplasty: a cohort of 302 patients with 2 implants of similar design
Barda, Beatrice; Ame, Shaali M.; Ali, Said M.; Albonico, Marco; Puchkov, Maxim; Huwyler, Jörg; Hattendorf, Jan; Keiser, Jennifer
2018
Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections : a randomised, non-inferiority, single-blind trial
Barda, Beatrice; Coulibaly, Jean T.; Puchkov, Maxim; Huwyler, Jörg; Hattendorf, Jan; Keiser, Jennifer
2016
Efficacy and safety of moxidectin, synriam, synriam-praziquantel versus praziquantel against schistosoma haematobium and S. mansoni infections: a randomized, exploratory phase 2 trial